| Literature DB >> 31455309 |
O Shoshany1,2, T Erlich3,4, S Golan5,3, N Kleinmann3,4, J Baniel5,3, B Rosenzweig3,4, A Eisner3,4, Y Mor3,4, J Ramon3,4, H Winkler3,4, D Lifshitz5,3.
Abstract
BACKGROUND: To compare quality of life (QoL) indices between ureteral stent (DJS) and nephrostomy tube (PCN) inserted in the setting of acute ureteral obstruction.Entities:
Keywords: Acute ureteral obstruction; Double J stent; Nephrostomy tube; Quality of life
Mesh:
Year: 2019 PMID: 31455309 PMCID: PMC6712738 DOI: 10.1186/s12894-019-0510-4
Source DB: PubMed Journal: BMC Urol ISSN: 1471-2490 Impact factor: 2.264
Patients’ characteristics and outcomes
| DJS ( | PCN ( | ||
|---|---|---|---|
| Pre-drainage patients’ characteristics | |||
| Age (years) | 55 (39.5–70.5) | 54 (46.5–61) | 0.787 |
| Gender- Female | 15 (33%) | 13 (43%) | 0.467 |
| BMI (kg/m2) | 27.6 (24.8–30.1) | 27.7 (23.3–31) | 0.944 |
| Hypertension | 24 (53.3%) | 13 (43.3%) | 0.683 |
| Diabetes mellitus | 14 (31.1%) | 7 (23.3%) | 0.622 |
| Ischemic heart disease | 8 (17.7%) | 7 (23.3%) | 0.775 |
| Previous endourological procedures | 14 (31.1%) | 9 (30%) | 1 |
| Baseline eGFR (MDRD, mL/min/1.73 m2) | 85.5 (69.3–90.6) | 69 (58.1–80.4) |
|
| eGFR at presentation (MDRD, mL/min/1.73 m2) | 60.3 (41.3–75.6) | 41.2 (33–59) |
|
| Positive urine cultures | 25.6% | 40.7% | 0.199 |
| Indication for drainage – Fever≥30oc | 15 (33.3%) | 16 (53.3%) | 0.099 |
| Indication for drainage - Renal Failure (eGFR≤60 mL/min/1.73 m2) | 10 (22.2%) | 10 (33.3%) | 0.301 |
| Stone diameter (mm) | 8 (7–11) | 8 (6–12.3) | 0.872 |
| Stone location-Proximal | 55% | 64% | 0.469 |
| Stone location-Distal | 45% | 36% | 0.469 |
| Post drainage outcomes | |||
| Post procedure hospitalization Days | 1 (1–3) | 4 (2–6) |
|
| Post Procedural Pain (VAS) | 1.02 ± 2.04 | 1.19 ± 1.52 | 0.283 |
| Days to baseline eGFR @ | 1 (1–2) | 2 (1–3) |
|
| Days to Temp ≤37.5 @@ | 1 (1–1.5) | 1 (1–1.75) | 1 |
| Time to WBC ≤10,000 white blood cells per microliter (Days) @@@ | 1.5 (1–2) | 2 (1–4) | 0.167 |
| Complications 1st procedure | 6 (11%) | 1 (3.3%) | 0.226 |
| Time from 1st to 2nd operation (Days) | 47 (29–71) | 20 (12–27) |
|
Data presented as Median (IQR 25–75) or Mean ± STD as appropriate
The Modification of Diet in Renal Disease Study equation
@ For patients with renal failure at presentation
@@ For patients with fever at presentation
@@@ For patients with leukocytosis at presentation
In bold - statistically significant result
QoL outcomes - ‘Tube symptoms’ questionnaire
| At discharge after urgent drainage | Upon arrival for definitive stone treatment | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DJS | PCN | p value | DJS | PCN | ||||||||
| Q1 Pain | 45.5% | 1.73 ± 0.94 | 48.3% | 1.83 ± 1 | 1 | 0.755 | 76.7% | 2.13 ± 0.9 | 50% | 1.73 ± 0.88 | 0.076 | 0.082 |
| Q2 Need of analgesia | 40.1% | 1.55 ± 0.74 | 62.1% | 1.86 ± 0.79 | 0.164 | 0.138 | 50% | 1.8 ± 1 | 40.1% | 1.59 ± 0.85 | 0.581 | 0.461 |
| Q3 Urinary discomfort | 80.1% | 2.71 ± 1.1 | 31% | 1.59 ± 0.98 |
|
| 80.6% | 2.55 ± 1.06 | 45.5% | 1.91 ± 1.15 |
|
|
| Q4 Hematuria | 54.5% | 2 ± 1.15 | 37.9% | 1.62 ± 0.9 | 0.268 | 0.216 | 48.4% | 1.87 ± 1.02 | 27.3% | 1.45 ± 0.91 | 0.159 | 0.104 |
| Q5 Mobility | 42.9% | 1.71 ± 0.96 | 86.2% | 2.66 ± 1.04 |
|
| 32.3% | 1.55 ± 0.89 | 45.5% | 1.82 ± 1.05 | 0.395 | 0.317 |
| Q6 Personal hygiene | 33.3% | 1.43 ± 0.68 | 60.7% | 2.18 ± 1.09 | 0.084 |
| 25.8% | 1.35 ± 0.66 | 40.1% | 1.77 ± 1.07 | 0.371 | 0.155 |
Data presented as percentage of symptomatic patients (reporting any symptoms) and frequency score as reported using a 4 points scale
In bold - statistically significant result
QoL outcomes - EQ-5D questionnaire
| At discharge after urgent drainage | At definitive stone treatment | |||||
|---|---|---|---|---|---|---|
| DJS | PCN | p value | DJS | PCN | ||
| Q1 Mobility | 16.60% | 34.50% | 0.102 | 25.80% | 18.20% | 0.51 |
| Q2 Self-care | 7.10% | 37.90% |
| 9.70% | 9.10% | 0.944 |
| Q3 Usual activities | 19% | 57.70% |
| 38.70% | 28.60% | 0.39 |
| Q4 Pain/discomfort | 47.60% | 53.60% | 0.632 | 67.70% | 42.90% | 0.082 |
| Q5 Anxiety/depression | 35.70% | 20.70% | 0.199 | 19.40% | 0% |
|
| “Health state” score | 72.6 ± 22 | 68.6 ± 20 | 0.44 | 68.6 ± 25 | 83.2 ± 12.1 |
|
In bold - statistically significant result